Centessa Pharmaceuticals Announces Presentation at the SVB Securities Global Biopharma Conference
February 02 2023 - 7:00AM
Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage
pharmaceutical company focused on discovering and developing
medicines that are transformational for patients, today announced
that members of its management team will participate in a fireside
chat at the virtual SVB Securities Global Biopharma Conference
on Tuesday, February 14, 2023 at 8:00 a.m. ET.
A webcast of the fireside chat, as well as an archived
recording, will be available under the “Events and Publications”
tab on the investor relations section of the Centessa
Pharmaceuticals website at
https://investors.centessa.com/events-presentations.
About Centessa Pharmaceuticals Centessa
Pharmaceuticals plc is a clinical-stage pharmaceutical company that
aims to discover and develop medicines that are transformational
for patients. Our programs span discovery-stage to late-stage
development and cover a range of high-value indications. We operate
with the conviction that each one of our programs has the potential
to change the current treatment paradigm and establish a new
standard of care. For more information, visit www.centessa.com,
which does not form part of this release.
Contact:
Kristen K. Sheppard, Esq.SVP of Investor
Relationsinvestors@centessa.com
Centessa Pharmaceuticals (NASDAQ:CNTA)
Historical Stock Chart
From Sep 2024 to Oct 2024
Centessa Pharmaceuticals (NASDAQ:CNTA)
Historical Stock Chart
From Oct 2023 to Oct 2024